DK557383A - Monoclone antistoffer og deres anvendelse - Google Patents

Monoclone antistoffer og deres anvendelse Download PDF

Info

Publication number
DK557383A
DK557383A DK557383A DK557383A DK557383A DK 557383 A DK557383 A DK 557383A DK 557383 A DK557383 A DK 557383A DK 557383 A DK557383 A DK 557383A DK 557383 A DK557383 A DK 557383A
Authority
DK
Denmark
Prior art keywords
monoclone antibodies
monoclone
antibodies
Prior art date
Application number
DK557383A
Other languages
English (en)
Other versions
DK557383D0 (da
Inventor
Betty Ann Diamond
Original Assignee
Univ Yeshiva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yeshiva filed Critical Univ Yeshiva
Publication of DK557383D0 publication Critical patent/DK557383D0/da
Publication of DK557383A publication Critical patent/DK557383A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK557383A 1982-12-03 1983-12-02 Monoclone antistoffer og deres anvendelse DK557383A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44671882A 1982-12-03 1982-12-03
US06/552,290 US4692416A (en) 1982-12-03 1983-11-16 Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus

Publications (2)

Publication Number Publication Date
DK557383D0 DK557383D0 (da) 1983-12-02
DK557383A true DK557383A (da) 1984-06-04

Family

ID=27034715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK557383A DK557383A (da) 1982-12-03 1983-12-02 Monoclone antistoffer og deres anvendelse

Country Status (11)

Country Link
US (1) US4692416A (da)
EP (1) EP0113431B1 (da)
AU (1) AU566246B2 (da)
CA (1) CA1215009A (da)
DE (1) DE3382009D1 (da)
DK (1) DK557383A (da)
ES (1) ES8607024A1 (da)
FI (1) FI834424A (da)
IL (1) IL70366A (da)
NO (1) NO163039C (da)
NZ (1) NZ206467A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
ATE45285T1 (de) * 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
JPS61205862A (ja) * 1985-03-08 1986-09-12 Shionogi & Co Ltd アレルゲン特異ＩｇＧ抗体測定用試薬
US4865970A (en) * 1986-02-28 1989-09-12 Hoffmann-La Roche Inc. Method of detecting ribosomal protein antibodies in systemic lupus erythematosus
DE3609271A1 (de) * 1986-03-19 1987-09-24 Boehringer Mannheim Gmbh Verfahren und reagenz zum nachweis von autoimmunerkrankungen, arzneimittel zur behandlung von autoimmunerkrankungen sowie hierzu geeignete antiparatypische antikoerper
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen
US5428132A (en) * 1987-10-11 1995-06-27 United States Of America Conjugate and method for integration of foreign DNA into cells
PT89107A (pt) * 1987-11-30 1989-11-30 Idec Pharma Corp Metodo e meios para a seleccao de anticorpos anti-idiotipos e seu uso para o diagnostico, monitorizacao, tratamento e/ou prevencao de doencas cancerosas, da autoimunidade ou infecciosas
US6232444B1 (en) 1990-01-29 2001-05-15 The Regents Of The University Of California Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupus
EP0535032A1 (en) * 1990-06-08 1993-04-07 Symbicom Ab Therapy and prophylaxis of autoimmune diseases
US7888458B1 (en) 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
WO1996037225A1 (en) * 1995-05-25 1996-11-28 Oklahoma Medical Research Foundation Method for treatment of sle
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
EP2183596B1 (en) * 2007-07-24 2012-10-03 ITH Immune Therapy Holdings AB Method and means for prediction of systemic lupus erythematosus susceptibility
US8283408B2 (en) 2010-02-26 2012-10-09 Hexcel Corporation Thermoplastic-toughened cyanate ester resin composites with low heat release properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234563A (en) * 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4493899A (en) * 1981-10-16 1985-01-15 City Of Hope Method of testing for particular antibodies in the serum of a patient
EP0091760B1 (en) * 1982-04-09 1986-07-02 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies

Also Published As

Publication number Publication date
EP0113431A2 (en) 1984-07-18
AU2171283A (en) 1984-06-07
NO163039B (no) 1989-12-11
AU566246B2 (en) 1987-10-15
ES8607024A1 (es) 1986-06-16
FI834424A (fi) 1984-06-04
CA1215009A (en) 1986-12-09
EP0113431B1 (en) 1990-11-22
DE3382009D1 (de) 1991-01-03
FI834424A0 (fi) 1983-12-02
DK557383D0 (da) 1983-12-02
NO163039C (no) 1990-03-21
NZ206467A (en) 1986-11-12
NO834434L (no) 1984-06-04
ES527730A0 (es) 1986-06-16
US4692416A (en) 1987-09-08
EP0113431A3 (en) 1986-08-27
IL70366A0 (en) 1984-03-30
IL70366A (en) 1987-11-30

Similar Documents

Publication Publication Date Title
NO169188C (no) Kombinert sluseroerventil og stengeventil
DK155583D0 (da) Hydantoiner, deres fremstilling og anvendelse
DK401583A (da) Parenkymal celle-cellulose og beslaegtede materialer
DK41484A (da) Beta-phenethanolaminer og deres anvendelse
DK300782A (da) Dyrefoderblok fremstillet af melasse og calciumoxid
NO813804L (no) Substituerte pyrimidiner og fremgangsmaate for deres fremstilling
DK557383A (da) Monoclone antistoffer og deres anvendelse
DK391785D0 (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
IT1167391B (it) Carbossi e carbossi sostituiti alcanoil e cicloalcanoil peptidi
NO167093C (no) 17-(isocyano-sylfonylmetylen)-stereoider og deres fremstilling.
DK340383D0 (da) Monoklone igm-antistoffer og fremgangsmade til deres fremstilling
DK158400C (da) Vantskrue
DK58581A (da) Thiolestere deres fremstilling og anvendelse
NO170691C (no) Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
DK556483A (da) Benzofuranylderivater og deres fremstilling
DK152864C (da) Ildfast sten
TR22157A (tr) Herbisid bilesikler ve bilesimler
DK356481A (da) Hetero-prostaglandinderivater og deres fremstilling
NO830416L (no) Peptidergotalkaloider og fremgangsmaaten for deres fremstilling
DK196683D0 (da) Substitueret urinstof og herbicid indeholdende dette
DK522883A (da) 2-heterocyclylthio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK156783A (da) N-pteridinylurinstoffer, deres fremstilling og anvendelse
DK162607C (da) Azopigmentpraeparater og deres anvendelse
DK325183D0 (da) Mumane monoclonale antistoffer og lymfokiner
IT1194260B (it) Linfochine e anticorpi monoclonali umani

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment